Candel Therapeutics Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | 100.0% | 100.0% | – | – | 100.0% | – | – | – | – | – | – | – | |
| 5,229.0% | 5,790.3% | – | – | 8,880.6% | 10,619.4% | 16,983.9% | 574.2% | 17,106.5% | 15,845.2% | 16,964.5% | 890.3% | – | – | – | 17.6% | 14.1% | – | – | 24.5% | – | – | – | – | – | – | – | |
| -5,129.0% | -5,690.3% | 100.0% | 100.0% | -8,780.6% | -10,519.4% | 100.0% | -474.2% | 100.0% | 100.0% | 100.0% | -790.3% | – | – | – | 82.4% | -14.1% | – | – | -24.5% | – | – | – | – | – | – | – | |
| 5,229.0% | 5,790.3% | 5,848.4% | 11,400.0% | 8,880.6% | 10,619.4% | 16,983.9% | 11,858.1% | 17,474.2% | 16,200.0% | 17,341.9% | 15,148.4% | – | – | – | 391.1% | 231.0% | – | – | 481.7% | – | – | – | – | – | – | – | |
| 2,348.4% | 2,758.1% | 3,119.4% | 7,632.3% | 6,038.7% | 6,580.6% | 9,016.1% | 12,635.5% | 11,612.9% | 12,135.5% | 11,406.5% | 10,193.5% | – | – | – | 172.3% | 214.0% | – | – | 332.4% | – | – | – | – | – | – | – | |
| 2,348.4% | 2,758.1% | 8,967.7% | 19,858.1% | 6,241.9% | 6,580.6% | 26,000.0% | 24,493.5% | 29,087.1% | 28,335.5% | 28,748.4% | 25,341.9% | – | – | – | 563.4% | 444.9% | – | – | 814.1% | – | – | – | – | – | – | – | |
| -7,477.4% | -8,448.4% | -8,867.7% | -19,758.1% | -15,022.6% | -17,100.0% | -25,900.0% | -24,967.7% | -28,987.1% | -28,235.5% | -28,648.4% | -26,132.3% | – | – | – | -581.0% | -444.9% | – | – | -814.1% | – | – | – | – | – | – | – | |
| 232.3% | 303.2% | 132.3% | 158.1% | 38.7% | 48.4% | 45.2% | 35.5% | 564.5% | 1,403.2% | 1,674.2% | 2,148.4% | – | – | – | 37.9% | 36.4% | – | – | 39.0% | – | – | – | – | – | – | – | |
| -5,716.1% | -9,277.4% | -8,238.7% | -33,800.0% | -14,445.2% | -55,096.8% | -52,135.5% | 5,148.4% | -2,819.4% | -13,383.9% | -28,025.8% | -16,396.8% | – | – | – | -624.7% | -462.9% | – | – | -1,407.3% | – | – | – | – | – | – | – | |
| 232.3% | 1,332.3% | 496.8% | 14,529.0% | 616.1% | 48.4% | 45.2% | 38.7% | -26,167.7% | -14,851.6% | -622.6% | -50,758.1% | – | – | – | 21.7% | 11.7% | – | – | – | – | – | – | – | – | – | – | |
| -5,716.1% | -9,277.4% | -8,238.7% | -33,800.0% | -14,445.2% | -55,096.8% | -52,135.5% | 5,148.4% | -2,819.4% | -13,383.9% | -28,025.8% | -16,396.8% | – | – | – | -624.7% | -462.9% | – | – | -1,407.3% | – | – | – | – | – | – | – | |
| -7,374.2% | -8,422.6% | -8,722.6% | -19,738.7% | -14,938.7% | -17,077.4% | -52,135.5% | -24,393.5% | -28,454.8% | -11,377.4% | -25,690.3% | -25,241.9% | – | – | – | -563.4% | -412.4% | – | – | -1,343.8% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.